AI and the Future of Cosmetic Dermatology: Experts Weigh in

While artificial intelligence (AI) is helping clinicians in medical dermatology improve diagnostic accuracy, streamline workflows, and develop patient treatment plans, its wide adoption for use in cosmetic dermatology is still in the early stages. According to Jeffrey Dover, MD, co-director of SkinCare Physicians in Chestnut Hill, Massachusetts, cosmetic dermatologists areContinue Reading

How the Chief AI Officer at Children’s National approaches clinical and admin automation

Editor’s Note: This is part two of a two-part interview. To read part one, click here. Children’s National Hospital, in Washington, D.C., is making robust use of artificial intelligence technologies in both clinical and administrative settings throughout the enterprise. While many hospitals and health systems across the country have begunContinue Reading

Most Kids With COVID-Linked MIS-C Recover by 6 Months

Children who were severely ill with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection appear to show excellent cardiovascular and noncardiovascular outcomes by 6 months, according to data published in JAMA Pediatrics. MIS-C is a life-threatening complication of COVID-19 infection and data on outcomes are limited, wrote theContinue Reading

Q&A: How serious is bird flu?

Please complete security verification This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our supportContinue Reading

How Long Does It Take to See a Neurologist?

The average wait time to see a neurologist following an initial referral was just over a month for older adults, with nearly 1 in 5 patients waiting more than 3 months, a cross-sectional analysis of Medicare data showed. Wait times were not affected by the number of available neurologists. However,Continue Reading

PSMA-PET Challenges Current Prostate Cancer Staging

TOPLINE:  Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) detected metastatic disease in 46% of patients with high-risk prostate cancer previously classified as nonmetastatic by conventional imaging. Results were positive in 84% of patients, with polymetastatic disease found in 24% of cases. METHODOLOGY: Recurrent nonmetastatic hormone-sensitive prostate cancer is characterized by increasingContinue Reading